Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
96.34% 106.98% 132.25% 122.67%

+8 more TTM periods

Piotroski F-Score
7 6 6 6
ROA
3.33% 3.33% 2.20% 2.16%
ROIC
15.65% 12.64% 20.29% 32.52%
Return on Tangible Assets
(256.39%) (1,370.54%) (64.24%) (51.08%)
Average Days of Receivables
27.91 27.64 29.11 28.65
Free Cash Flow per Share
21.26 8.23 18.79 16.55
Free Cash Flow
4,105.92 1,601.89 3,650.33 3,207.14
Other line items

Show all line items

Columns are period end dates